Get The Alerts + Report

REGENXBIO Inc. [RGNX]

Reporting date: 10/09/2025

⚠️ Neutral Insider Sale Detected

📝 What Happened

  • Insider: Simpson Curran
  • Role: Chief Executive Officer (Director)
  • Company: REGENXBIO Inc. (RGNX)
  • Transaction Date(s): 2025-10-09
  • Table I (Non-Derivative Securities)
    • Sale : 20,811.00
    • Average Sale Price: $12.62
    • Total Value: $262,634.82
    • Post-Transaction Direct Holdings: 216,162
    • Indirect Holdings: None reported
    • 10b5-1 Plan Used? Yes — disclosed in footnote

📄 Summary

Simpson Curran, Chief Executive Officer (Director) at REGENXBIO Inc. (RGNX), sold 20,811 shares on October 9, 2025, at an average price of $12.62, realizing proceeds of about ~$262,634.82. After the transaction, they now hold 216,162 shares directly; no indirect holdings reported. For retail traders, this is a neutral-to-slightly bearish event: planned sale under a 10b5-1 plan, modest relative to total holdings.

🔑 Interpretation

  • Type: Comp-related / pre-arranged — this sale was executed pursuant to a Rule 10b5-1 trading plan (footnote disclosed).
  • Disposition: Sold (disposed under an established 10b5-1 plan; executed over multiple trades per footnote).
  • Size Context: The sale represents approximately 8.8% of pre-transaction holdings (pre-sale ~236,973 shares). This is a modest, not large, reduction — consistent with routine liquidity or diversification rather than an immediate red-flag profit-taking event.
  • ATH Metric: The sale price ($12.62 VWAP) is not near an insider-timing spike — it sits well below the stock's historical peaks and above historical lows. Based on historical price context through the recent period, this trade does not appear timed to an all-time high or low and therefore is not overtly opportunistic relative to ATH/ATL extremes.
  • Outlier Check: Not unusually large compared with the remaining holdings and typical insider single-event sizes; no evidence in this filing of an unusually large or clustered disposition.

📊 Bullish or Bearish?

Neutral

Neutral. The filing shows a net sale (code S) by the CEO but it was executed under a disclosed 10b5-1 plan and is modest relative to total holdings; this looks like planned liquidity rather than an indicator of deteriorating insider conviction. Data is complete for this transaction but cluster activity cannot be determined from this filing alone.

✅ Bottom Line (Retail Takeaway)

This transaction looks like routine, planned liquidity rather than a standalone bearish signal. For retail traders, it’s noise — not a tradeable event unless corroborated by widescale insider selling from multiple senior officers or new, non-plan-driven dispositions.